...
首页> 外文期刊>Journal of Zhejiang University. Science, B >Validity and reliability testing of the Chinese (mainland) version of the 39-item Parkinson’s Disease Questionnaire (PDQ-39)
【24h】

Validity and reliability testing of the Chinese (mainland) version of the 39-item Parkinson’s Disease Questionnaire (PDQ-39)

机译:39-Item Parkinson病问卷(PDQ-39)的中国(大陆)版本的有效性和可靠性测试(PDQ-39)

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The 39-item Parkinson’s Disease Questionnaire (PDQ-39) has been tested in many languages, but not in Chinese mainland. We aimed to assess the Chinese (mainland) version of the PDQ-39. Seventy-one subjects with Parkinson’s disease (PD) completed the PDQ-39 and the Medical Outcomes Study 36-item Short Form Health Survey (SF-36). All subjects were retested with the PDQ-39 a week later. The united Parkinson’s disease rating scale (UPDRS) and the Hoehn and Yahr (H & Y) scale were also used to evaluate the subjects. reliability was assessed by Cronbach’s α and intra-class correlation coefficient (ICC). validity was examined in terms of agreement with SF-36, UPDRS, and H & Y scales. The Chinese (mainland) version of the PDQ-39 demonstrated acceptable reliability (Cronbach’s α: 0.84–0.88; ICC: 0.56–0.82). The item-total correlations (0.33–0.88) and scaling success rates (77.56%) indicated satisfactory convergent and discriminant validity of the PDQ-39 items. The correlations between related constructs of the PDQ-39 and UPDRS (r=0.44–0.68) and between those of the PDQ-39 and SF-36 (r=(?0.46)–(?0.69)) were all statistically significant (P<0.01). Except for stigma, cognitions, and bodily discomfort, all other dimensions of the PDQ-39 significantly discriminated patients at different H & Y stages indicated by the H & Y scale. Although our observations indicate that some problematic subscales of this version of the PDQ-39 could be improved upon, this study suggests acceptable reliability and validity of the Chinese (mainland) version of the PDQ-39.
机译:39-Item Parkinson的疾病问卷(PDQ-39)已经在许多语言中进行了测试,但不是在中国大陆。我们旨在评估PDQ-39的中国人(大陆)版本。七十一项受帕金森病(PD)的受试者完成了PDQ-39,医疗结果研究36项短型健康调查(SF-36)。每周用PDQ-39重新测试所有受试者。联合帕金森的疾病评级规模(UPDRS)和Hoehn和Yahr(H&Y)规模也用于评估受试者。通过Cronbach的α和类内相关系数(ICC)评估可靠性。在与SF-36,UPDRS和H&Y等级的协议中审查了有效性。中国(大陆)版本的PDQ-39展示可接受的可靠性(Cronbach的α:0.84-0.88; ICC:0.56-0.82)。项目总相关性(0.33-0.88)和缩放成功率(77.56%)表明PDQ-39项的令人满意的会聚和判别有效性。 PDQ-39和UPDR的相关构建与PDQ-39和SF-36的相关构建之间的相关性(R =(r =(α0.46) - (α0.69))都是统计学意义(P <0.01)。除了耻辱,认知和身体不适,PDQ-39的所有其他尺寸在H&Y规模所示的不同H&Y阶段的患者显着辨别。虽然我们的观察结果表明,这一版本的PDQ-39的一些有问题的分量可以改善,但本研究表明PDQ-39的中文(大陆)版本的可接受可靠性和有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号